Shashank Sama
Rating: 4.9 of 5
( out of 40 reviews )

Shashank Sama, MD

Languages spoken: English

  • Shashank Sama, MD is an Assistant Professor of Medicine in the Division of Oncology at the Huntsman Cancer Institute, University of Utah. He specializes in the treatment of gynecologic malignancies, including ovarian, uterine, and cervical cancers. In addition to his role at Huntsman Cancer Institute, Dr. Sama provides care for veterans at the George E. Wahlen Department of Veterans Affairs Medical Center in Salt Lake City, where he practices general medical oncology.

    Dr. Sama is committed to advancing care for women with gynecologic cancers by bringing cutting-edge clinical trials to patients in Utah. His research focuses on outcomes-based studies involving gynecologic tumors.

    Originally from the East Coast, Dr. Sama completed his internal medicine residency at the University of Connecticut before moving to Utah for a fellowship in Hematology and Medical Oncology at the University of Utah. During his fellowship, he served as Chief Hematology and Oncology Fellow. Beyond his clinical and research interests, Dr. Sama is deeply passionate about medical education and mentoring residents and fellows.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    National Board of Medical Examiners

    Patient Rating

    Rating: 4.9 out of 5
    4.9 /5
    ( out of 40 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    June 29, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr Sama is a great doctor and IÕm honored to be in his care through this journey that IÕm on. He really shows he cares and listen to what you have to say and respects you.

    May 31, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Has provided excellent care. Very compassionate, and listens to my concerns, answering all questions thoroughly and in away I can understand.

    April 25, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    He is seemingly willing to spend time listening and considering no matter what we have to say. Always asks if there are questions and patiently endures them! He is encouraging, upbeat and unflusterable! He is the best!

    February 28, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    He's very present with questions about his choices about your care and treatment. His team are able to reach Dr. Sama most of the time and he has kept up with hospital, doctor and urgent care visits within minutes of o

    February 27, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr. Sama is so very caring and attentive! Love Him!

    January 24, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Was so happy to meet him and extremely impressed!

    October 19, 2024
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Very thorough and understood my need to have Chemo done at UBMC in Roosevelt, UT due to logistics and weather concerns.

    July 19, 2024
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    He was very good. If I didn't want care closer to home I would be pleased to have him as my provider.

    July 05, 2024
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    He is a wizard! Anticipates questions and provides concise understandable answers to ANY concerns! Extraordinarily considerate!

  • Shashank Sama, MD is an Assistant Professor of Medicine in the Division of Oncology at the Huntsman Cancer Institute, University of Utah. He specializes in the treatment of gynecologic malignancies, including ovarian, uterine, and cervical cancers. In addition to his role at Huntsman Cancer Institute, Dr. Sama provides care for veterans at the George E. Wahlen Department of Veterans Affairs Medical Center in Salt Lake City, where he practices general medical oncology.

    Dr. Sama is committed to advancing care for women with gynecologic cancers by bringing cutting-edge clinical trials to patients in Utah. His research focuses on outcomes-based studies involving gynecologic tumors.

    Originally from the East Coast, Dr. Sama completed his internal medicine residency at the University of Connecticut before moving to Utah for a fellowship in Hematology and Medical Oncology at the University of Utah. During his fellowship, he served as Chief Hematology and Oncology Fellow. Beyond his clinical and research interests, Dr. Sama is deeply passionate about medical education and mentoring residents and fellows.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Assistant Professor (Clinical)
    Academic Divisions Oncology
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    National Board of Medical Examiners

    Education history

    Fellowship Hematology & Medical Oncology - University of Utah School of Medicine, Huntsman Cancer Institute Chief Fellow
    Fellowship Hematology & Medical Oncology - University of Utah School of Medicine, Huntsman Cancer Institute Fellow
    Residency Internal Medicine - University of Connecticut School of Medicine Resident
    Internship Internal Medicine - University of Connecticut School of Medicine Intern
    Professional Medical Medicine, Surgery - Osmania Medical College M.B.B.S.

    Selected Publications

    Journal Article

    1. Smith JT, Sama S, Florou V, Nevala-Plagemann C, Garrido-Laguna I (2023). Durable response to first-line PARP inhibition in BRCA-mutated metastatic cholangiocarcinoma: case report. J Gastrointest Oncol, 14(6), 2637-2643. (Read full publication)
    2. Nevala-Plagemann C, Sama S, Ying J, Shen J, Haaland B, Florou V, Garrido-Laguna I (2022). A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer in the United States. J Natl Compr Canc Netw, 21(3), 257-264. (Read full publication)
    3. Sama S, Kerrigan K, Sinnott JA, Puri S, Akerley W, Haaland B, Patel S (2023). Real-world comparison of survival outcomes with cisplatin versus carboplatin in patients with limited-stage small-cell lung cancer. Cancer Treat Res Commun, 35, 100686. (Read full publication)
    4. Lopetegui Lia N, Luke A, Asad SD, Sama S, Wolansky LJ, Hegde UP (2020). Intracranial bleeding following soccer-related head trauma in a young student with occult factor VII deficiency. Clin Case Rep, 8(11), 2148-2151. (Read full publication)
    5. Hennessey A, Buller D, Sama S, Girard E, Clement J, Ristau BT (2019). Case report: Adenosquamous carcinoma of the prostate with greater than 20 month response to multimodal therapy. Urol Case Rep, 29, 101084. (Read full publication)
    6. Lima G, Kahn A, Sama S, Savage J (2019). Aseptic Meningitis as an Immune-Related Adverse Event after Pembrolizumab. Case Rep Oncol Med, 2019, 7183747. (Read full publication)
    7. Sama S, Hadfield MJ, Lopetegui Lia N, Vredenburgh J (2019). Hyperprogression in PDL1 Expressive, Recurrent Gastroesophageal-junction Adenocarcinoma After Pembrolizumab. Cureus, 11(6), e4862. (Read full publication)
    8. Kethireddy N, Sama S (2019). Cerebral Sinus Venous Thrombosis in the Setting of Acute Mastoiditis. Cureus, 11(2), e4023. (Read full publication)